Table 4. FT stability of 5 calibration sera for 7 anti-PnPS (acceptable range: within ± 20%).
| PnPS | FT cycle* | |||||||
|---|---|---|---|---|---|---|---|---|
| Serum 748 | Serum 752 | |||||||
| 1† | 2 | 3 | 4 | 1† | 2 | 3 | 4 | |
| 4 | 100.00 | 94.67 | 106.67 | 107.42 | 100.00 | 91.52 | 108.30 | 105.79 |
| 6B | 100.00 | 97.88 | 100.31 | 105.56 | 100.00 | 98.19 | 100.29 | 104.48 |
| 9V | 100.00 | 102.72 | 99.56 | 104.10 | 100.00 | 92.01 | 103.56 | 107.22 |
| 14 | 100.00 | 93.94 | 96.08 | 105.19 | 100.00 | 92.39 | 102.40 | 104.52 |
| 18C | 100.00 | 94.86 | 100.90 | 98.58 | 100.00 | 89.58 | 103.13 | 106.08 |
| 19F | 100.00 | 99.82 | 101.15 | 104.60 | 100.00 | 91.05 | 105.21 | 108.03 |
| 23F | 100.00 | 97.33 | 99.50 | 106.22 | 100.00 | 93.79 | 106.82 | 100.72 |
FT = freeze thaw, PnPS = pneumococcal polysaccharide.
*Freeze thaw cycle: sera were subjected to 4 freeze thaw cycles. †Relative to FT 1 (%) = (based upon mean value) FT 2/FT 1 × 100.